Zoetis Inc. Stock: price and insider trades · United States

This page follows insider dealings at Zoetis Inc. as filed with SEC (Form 4), a company from the Healthcare & Pharma sector based in Florham Park, United States. The group dates from 1952. In the past year (18 October 2025 to 18 October 2026), 41 filings came from 19 insiders.

Only purchases show up on the open market, 2 purchases in all worth €557k, filed by 2 insiders. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Damelio Frank A filed the largest purchase, €428k, on 13 May 2026, which represents 0.0014% of the company's market value. On the buying side, the filings list 2 senior executives among the declarants.

With 41 filings in twelve months, the company is more active than the median of 19 filings across the 5,811 companies we follow on the same exchange. The full history, which starts in 2016, counts 2 purchases against 27 sales. For the fiscal year to 31 December 2025, the annual 10-K puts revenue at 9.47 bn USD and net income at 2.67 bn USD, and the dividend at 2.03 USD per share.

Within a 30-day window, 2 purchases overlapped with buying by a second insider. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The most recent open-market purchase was published on 13 May 2026, 158 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4.

In the same sector, recent insider purchases at Cooper Companies, Inc. and Anixa Biosciences Inc also feature in our signals. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.